Sign In
Buy MDGL
$512.88
+7.13 (+1.41%)
At Close: Jun 22, 2026
H.C. Wainwright Initiates a Hold Rating on Intercept Pharma (ICPT) - Markets
10:22am, Thursday, 25'th Jun 2020
In a report released today, Ed Arce from H.C. Wainwright initiated coverage with a Hold rating on Intercept Pharma (ICPT
Poxel annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 24 juin 2020
12:00am, Thursday, 25'th Jun 2020
Regulatory News : POXEL SA (Paris:POXEL) (Euronext : POXEL - FR0012432516), société biopharmaceutique spécialisée dans le développement de traitements
Stifel Nicolaus Believes Momenta Pharma (NASDAQ: MNTA) Won't Stop Here - Markets
09:09pm, Wednesday, 24'th Jun 2020
Stifel Nicolaus analyst Derek Archila reiterated a Buy rating on Momenta Pharma (MNTA – Research Report) today. The company’s shares
Combination Pill From Myovant Reduces Pain From Endometriosis, Trial Shows
01:32pm, Wednesday, 24'th Jun 2020
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
Advocates Want More Warnings From FDA On Diabetes Drug Linked To Fatal Reactions
01:32pm, Wednesday, 24'th Jun 2020
Because the drug can cause a potentially fatal condition called ketoacidosis in diabetic patients, advocates are calling on the FDA to issue a “black box” warning–the most severe …
Poxel : premiers résultats positifs dans la NASH | Zone bourse
09:28am, Wednesday, 24'th Jun 2020
Pour recevoir l'information de POXEL en temps réel, faites-en la demande à [email protected]
Critical Contrast: GENFIT S A/ADR (GNFT) and Its Peers
01:36am, Wednesday, 24'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare GENFIT S A/AD
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, in
ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents | | IT Business Net
03:11pm, Tuesday, 23'rd Jun 2020
Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform Capabilities ANN ARBOR, MI / ACCESSWIRE / June 23, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a
Fate of Intercept's NASH drug clouded by murky FDA review delays
01:49pm, Tuesday, 23'rd Jun 2020
The agency had planned to announce its decision on whether or not to approve the first treatment for the fatty liver disease known as NASH this week.
Two Sigma Investments LP Purchases 15,717 Shares of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)
08:10am, Tuesday, 23'rd Jun 2020
Two Sigma Investments LP raised its position in shares of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) by 698.5% in the first quarter, according to the company in its most recent filing with the Securit
Ayala Pharmaceuticals (AYLA) Receives a Buy from Oppenheimer - Markets
03:14am, Tuesday, 23'rd Jun 2020
In a report released yesterday, Jay Olson from Oppenheimer maintained a Buy rating on Ayala Pharmaceuticals (AYLA – Research Report),
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
